Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comfort and ease of use of CNTX-4975-05 injection in knee osteoarthritis
NCT03661996Phase 3Completed
- Sponsor
- Centrexion Therapeutics
- Start
- Sep 2018
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capsaicin in osteoarthritis (OA), sponsored by Centrexion Therapeutics. Started Sep 2018; status: completed.
02
Drugs
capsaicin
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT03661996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03661996.